These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2142113)

  • 1. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.
    Burget DW; Chiverton SG; Hunt RH
    Gastroenterology; 1990 Aug; 99(2):345-51. PubMed ID: 2142113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
    Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
    Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease.
    Howden CW; Burget DW; Hunt RH
    Scand J Gastroenterol Suppl; 1994; 201():79-82. PubMed ID: 8047830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between suppression of acidity and gastric ulcer healing rates.
    Howden CW; Hunt RH
    Aliment Pharmacol Ther; 1990 Feb; 4(1):25-33. PubMed ID: 2151756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing acid suppression for treatment of acid-related diseases.
    Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between inhibition of acid secretion and healing of peptic ulcers.
    Chiverton SG; Hunt RH
    Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
    Bianchi Porro G; Parente F; Sangaletti O
    Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between acid suppression and peptic ulcer healing.
    Hunt RH; Howden CW; Jones DB; Burget DW; Kerr GD
    Scand J Gastroenterol Suppl; 1986; 125():22-31. PubMed ID: 3469740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between acid reduction and rate of ulcer healing.
    Rune SJ
    Scand J Gastroenterol Suppl; 1988; 155():12-5. PubMed ID: 3072663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antacids and anticholinergics in the treatment of duodenal ulcer.
    Walan A
    Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric and duodenal ulcer healing under placebo treatment.
    Scheurer U; Witzel L; Halter F; Keller HM; Huber R; Galeazzi R
    Gastroenterology; 1977 May; 72(5 Pt 1):838-41. PubMed ID: 849813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the pharmacology of acid control in acid-related disorders.
    Howden CW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):17S-19S; discussion 19S-21S. PubMed ID: 9127622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antacids for duodenal ulcer: current role.
    Bianchi Porro G; Parente F
    Scand J Gastroenterol Suppl; 1990; 174():48-53. PubMed ID: 2205900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium-containing antacids in the therapy of duodenal ulcers].
    Weingart J; Kunert H
    Fortschr Med; 1981 Feb; 99(8):278-82. PubMed ID: 7274971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
    Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
    Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates.
    Howden CW; Jones DB; Peace KE; Burget DW; Hunt RH
    Dig Dis Sci; 1988 May; 33(5):619-24. PubMed ID: 3282850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H2-receptor antagonists in the treatment of duodenal ulcers.
    Bank S; Barbezat GO; Novis BH; Tim LO; Odes HS; Helman C; Narunsky L; Duys PJ; Marks IN
    S Afr Med J; 1976 Oct; 50(44):1781-5. PubMed ID: 11564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
    Deakin M; Williams JG
    Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.